News Conference News AHA 2022 ‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE Michael O'Riordan November 06, 2022
News Daily News US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI Caitlin E. Cox October 20, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022
News Conference News EACTS 2022 FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry Michael O'Riordan October 07, 2022
News Daily News Most Patient-Reported Outcome Measures in CVD Fall Short L.A. McKeown September 23, 2022
News Conference News TCT 2022 Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes Todd Neale September 22, 2022
News Conference News TCT 2022 CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA Yael L. Maxwell September 21, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
Presentation TCT 2022 TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy Presenter: Mick Renkens September 17, 2022
Presentation TCT 2022 TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial Presenter: Zardasht Oqab September 17, 2022
Presentation TCT 2022 TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial Presenter: Kevin Bainey September 17, 2022
News Industry News TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism September 13, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News ESC 2022 Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE Michael O'Riordan August 31, 2022
News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Conference News ESC 2022 Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration Michael O'Riordan August 29, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022